Pricing Log in Create free account

Haleon PLC Sponsored ADR (HLN) vs Neurocrine Biosciences, Inc. (NBIX)

Haleon PLC Sponsored ADR and Neurocrine Biosciences, Inc. are both Drug Manufacturers Specialty & Generic companies. Haleon PLC Sponsored ADR is the larger, with a market value of $43.7B against $13.9B — 3.1× the size. Neurocrine Biosciences, Inc. trades at the lower P/E: 19.2× against 22.6×. Neurocrine Biosciences, Inc. has the higher net margin (20.9% vs 13.8%) and the higher return on invested capital (15.0% vs 0.00%). Across the 21 metrics below, Neurocrine Biosciences, Inc. leads on 14 and Haleon PLC Sponsored ADR on 7.

Valuation

Metric HLN NBIX Drug Manufacturers Specialty & Generic median
P/E 22.58 19.25 19.25
P/S 2.57 4.06 2.11
P/B 2.11 3.71 1.78
Price to free cash flow 10.24 15.75 16.14
EV/EBITDA 13.30 16.66 12.58
EV/Sales 3.12 4.11 2.73
Earnings yield 4.43% 5.19% (4.38%)
Free cash flow yield 9.77% 6.35% 0.00%

Profitability

Metric HLN NBIX Drug Manufacturers Specialty & Generic median
Gross margin 62.22% 97.94% 53.94%
Operating margin 17.93% 23.56% 0.00%
Net margin 13.79% 20.91% 0.00%
Free cash flow margin 0.00% 25.80% 0.00%
Return on equity 0.00% 22.09% (0.40%)
Return on assets 0.00% 15.26% (3.32%)
Return on invested capital 0.00% 15.04% 0.00%

Growth

Metric HLN NBIX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 34.42% 10.01%
EPS growth (last fiscal year) 22.50% 41.95% 49.06%
Revenue growth, 5-year CAGR 1.43% 22.29% 6.74%
Net income growth, 5-year CAGR 6.98% 3.28% 0.00%

Health

Metric HLN NBIX Drug Manufacturers Specialty & Generic median
Debt to equity 0.50 0.00 0.05
Current ratio 0.69 1.87 2.31
Net debt to EBITDA 2.63 (2.33) 0.97

Dividend

Metric HLN NBIX Drug Manufacturers Specialty & Generic median
Dividend yield 1.95% — 1.57%
Payout ratio — — 0.27

Size

Metric HLN NBIX Drug Manufacturers Specialty & Generic median
Market cap 43.71b 13.92b 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack